Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies

BACKGROUND: Antiphospholipid syndrome (APS) is an autoimmune disease characterised by the presence of antiphospholipid (aPL) antibodies that have prothrombotic activity. Antiphospholipid antibodies are associated with an increased risk of pregnancy complications (recurrent miscarriage, premature bir...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cochrane Database Syst Rev
Autors principals: Bala, Malgorzata M, Paszek, Elżbieta, Lesniak, Wiktoria, Wloch‐Kopec, Dorota, Jasinska, Katarzyna, Undas, Anetta
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2018
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6513409/
https://ncbi.nlm.nih.gov/pubmed/30004572
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD012534.pub2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars